High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Inclusion Criteria:

Patient must be 18 years of age or older.
Patients must have either biopsy proven or radiographically suspected non-small cell lung cancer.
Patients must have disease in the chest that is felt to be surgically resectable.
ECOG performance status of 0-2.
Ability to understand and the willingness to sign an IRB-approved informed consent document

Exclusion Criteria:

Patients younger than 18 years of age
Women who are pregnant or breast feeding.
Patients may not be receiving any other investigational agents for the treatment of nonsmall cell lung cancer.
Patients may not be taking the following medications: high dose vitamin A supplement (multivitamin supplements prohibited only if vitamin A content is greater than 3,500 international units), bexarotene, alitretinoin, tretinoin, adapalene, isotretinoin, acitretin, doxycycline, minocycline, or demeclocycline,
Uncontrolled intercurrent illness including, but not limited to, pancreatitis, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
Hypervitaminosis A - toxic effects of ingesting too much vitamin A.